ETOR Etoro Group | $75.97
+10.6% | 6/9/2025 | Initiated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight | $84.00 | High | View details for Cantor Fitzgerald rating of Etoro Group (NASDAQ:ETOR) on 6/9/2025 |
DCBO Docebo | $28.05
+3.9% | 6/9/2025 | Initiated by | Cantor Fitzgerald | Analyst Yi Fu Lee | Overweight | $35.00 | Low | View details for Cantor Fitzgerald rating of Docebo (NASDAQ:DCBO) on 6/9/2025 |
AVGO Broadcom | $244.28
-1.1% | 6/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $300.00 | Medium | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 6/6/2025 |
RBRK Rubrik | $93.27
-4.7% | 6/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $95.00 -> $115.00 | Low | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 6/6/2025 |
CPRX Catalyst Pharmaceuticals | $25.84
-0.1% | 6/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Kim | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 6/5/2025 |
ACAD ACADIA Pharmaceuticals | $22.30
+1.5% | 6/5/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Kim | Strong-Buy | | High | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 6/5/2025 |
CIFR Cipher Mining | $4.14
+6.2% | 6/5/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $4.00 -> $6.00 | High | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 6/5/2025 |
MDB MongoDB | $217.23
-1.3% | 6/5/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $252.00 -> $271.00 | High | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 6/5/2025 |
GHRS GH Research | $13.70
+9.6% | 6/4/2025 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of GH Research (NASDAQ:GHRS) on 6/4/2025 |
NAMS NewAmsterdam Pharma | $20.16
+0.1% | 6/4/2025 | Initiated by | Cantor Fitzgerald | Analyst S. Seedhouse | Overweight | $42.00 | High | View details for Cantor Fitzgerald rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 6/4/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
KVYO Klaviyo | $34.76
+2.0% | 6/3/2025 | Upgraded by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 6/3/2025 |
CXM Sprinklr | $8.69
-0.8% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Neutral | $8.00 | Low | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 6/3/2025 |
FRSH Freshworks | $15.95
+1.7% | 6/3/2025 | Upgraded by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 6/3/2025 |
TYL Tyler Technologies | $580.36
+0.7% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Neutral | $600.00 | Low | View details for Cantor Fitzgerald rating of Tyler Technologies (NYSE:TYL) on 6/3/2025 |
SPSC SPS Commerce | $141.11
-0.9% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight | $170.00 | Low | View details for Cantor Fitzgerald rating of SPS Commerce (NASDAQ:SPSC) on 6/3/2025 |
CRM Salesforce | $272.36
-0.8% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight -> Overweight | $325.00 | Low | View details for Cantor Fitzgerald rating of Salesforce (NYSE:CRM) on 6/3/2025 |
QTWO Q2 | $91.01
-0.3% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight | $110.00 | Low | View details for Cantor Fitzgerald rating of Q2 (NYSE:QTWO) on 6/3/2025 |
HUBS HubSpot | $606.92
-0.4% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight | $775.00 | Low | View details for Cantor Fitzgerald rating of HubSpot (NYSE:HUBS) on 6/3/2025 |
BRZE Braze | $30.65
+3.1% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Braze (NASDAQ:BRZE) on 6/3/2025 |
BL BlackLine | $57.30
-0.1% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Neutral | $58.00 | Low | View details for Cantor Fitzgerald rating of BlackLine (NASDAQ:BL) on 6/3/2025 |
AGYS Agilysys | $113.70
+0.7% | 6/3/2025 | Initiated by | Cantor Fitzgerald | Analyst Matthew Vanvliet | Overweight | $125.00 | Low | View details for Cantor Fitzgerald rating of Agilysys (NASDAQ:AGYS) on 6/3/2025 |
SPT Sprout Social | $21.88
+0.7% | 6/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Vanvliet | Overweight -> Neutral | $24.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 6/3/2025 |
UTHR United Therapeutics | $328.40
+0.8% | 6/2/2025 | Initiated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight | $405.00 | High | View details for Cantor Fitzgerald rating of United Therapeutics (NASDAQ:UTHR) on 6/2/2025 |
CRWD CrowdStrike | $464.39
-0.9% | 5/30/2025 | Target Raised by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $440.00 -> $475.00 | High | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 5/30/2025 |
ESTC Elastic | $85.82
-0.7% | 5/30/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $109.00 -> $92.00 | High | View details for Cantor Fitzgerald rating of Elastic (NYSE:ESTC) on 5/30/2025 |
MRVL Marvell Technology | $69.14
+1.2% | 5/30/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $60.00 | Medium | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 5/30/2025 |
ZS Zscaler | $299.90
-1.0% | 5/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $250.00 -> $275.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 5/27/2025 |
CMPS COMPASS Pathways | $4.67
-2.7% | 5/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $12.00 | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 5/27/2025 |
PRTA Prothena | $5.25
-3.0% | 5/27/2025 | Downgraded by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Neutral | | High | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 5/27/2025 |
S SentinelOne | $18.12
-1.3% | 5/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of SentinelOne (NYSE:S) on 5/23/2025 |
SERV Serve Robotics | $12.57
-2.9% | 5/22/2025 | Initiated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight | | Low | View details for Cantor Fitzgerald rating of Serve Robotics (NASDAQ:SERV) on 5/22/2025 |
WIX Wix.com | $153.96
+1.1% | 5/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 5/22/2025 |
SLDB Solid Biosciences | $4.62
+1.8% | 5/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Solid Biosciences (NASDAQ:SLDB) on 5/22/2025 |
SNOW Snowflake | $210.75
0.0% | 5/22/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $183.00 -> $242.00 | High | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 5/22/2025 |
ZM Zoom Video Communications | $80.26
-0.1% | 5/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $87.00 -> $87.00 | High | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 5/22/2025 |
DOMO Domo | $14.25
-2.6% | 5/22/2025 | Target Raised by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $11.00 -> $12.00 | High | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 5/22/2025 |
SERV Serve Robotics | $12.57
-2.9% | 5/22/2025 | Upgraded by | Cantor Fitzgerald | Analyst Andres Sheppard | Strong-Buy | $17.00 | High | View details for Cantor Fitzgerald rating of Serve Robotics (NASDAQ:SERV) on 5/22/2025 |
EVLV Evolv Technologies | $5.43
-1.6% | 5/21/2025 | Upgraded by | Cantor Fitzgerald | Analyst B. Knoblauch | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 5/21/2025 |
JTKWY Just Eat Takeaway.com | $4.41
+0.3% | 5/19/2025 | Upgraded by | Cantor Fitzgerald | Analyst V. Bhardwaj | Hold | | N/A | View details for Cantor Fitzgerald rating of Just Eat Takeaway.com (OTC:JTKWY) on 5/19/2025 |
MRK Merck & Co., Inc. | $79.30
+0.4% | 5/20/2025 | Downgraded by | Cantor Fitzgerald | Analyst C. Gould | Overweight -> Cautious | | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 5/20/2025 |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) It could very well mark the beginning of a new multitrillion-dollar industrial revolution.
Up until now, we've imagined robots doing things like cleaning our homes, serving drinks at restaurants, greeting guests in hotel lobbies, stacking shelves in warehouses, and so on.
Very soon, there will be a robot that won't do any of that.
However, it's impact on the US economy and society will be FAR greater than anything we ever imagined. This little-known company holds nearly 100 patents and trades for around $7 |
SES SES AI | $1.04
-0.5% | 5/20/2025 | Initiated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight | $2.00 | High | View details for Cantor Fitzgerald rating of SES AI (NYSE:SES) on 5/20/2025 |
QURE uniQure | $16.90
-2.1% | 5/19/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 5/19/2025 |
MSTR Strategy | $392.12
+4.7% | 5/19/2025 | Reiterated by | Cantor Fitzgerald | - | Hold -> Hold | | Low | View details for Cantor Fitzgerald rating of Strategy (NASDAQ:MSTR) on 5/19/2025 |
STX Seagate Technology | $130.17
+2.5% | 5/19/2025 | Target Raised by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $110.00 -> $125.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 5/19/2025 |
PANW Palo Alto Networks | $196.33
-1.6% | 5/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $223.00 -> $223.00 | Low | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 5/19/2025 |
ADI Analog Devices | $227.66
+2.4% | 5/19/2025 | Target Raised by | Cantor Fitzgerald | Analyst C J Muse | Neutral -> Neutral | $230.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 5/19/2025 |
RCKT Rocket Pharmaceuticals | $3.02
-1.6% | 5/16/2025 | Target Raised by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $20.00 -> $30.00 | Low | View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/16/2025 |
NICE NICE | $175.42
-0.7% | 5/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $161.00 -> $161.00 | Low | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 5/16/2025 |
SEPN Septerna | $10.11
-1.0% | 5/16/2025 | Target Raised by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $20.00 -> $25.00 | Low | View details for Cantor Fitzgerald rating of Septerna (NASDAQ:SEPN) on 5/16/2025 |
ACHR Archer Aviation | $11.31
+11.0% | 5/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $13.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 5/16/2025 |
AMAT Applied Materials | $169.79
+1.8% | 5/12/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $220.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 5/12/2025 |
PGEN Precigen | $1.50
| 5/15/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Precigen (NASDAQ:PGEN) on 5/15/2025 |
BLTE Belite Bio | $61.40
+2.9% | 5/15/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Belite Bio (NASDAQ:BLTE) on 5/15/2025 |
LUCD Lucid Diagnostics | $1.30
+0.8% | 5/15/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $2.00 -> $2.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 5/15/2025 |
EXPE Expedia Group | $176.62
+0.0% | 5/15/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $170.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 5/15/2025 |
XGN Exagen | $7.17
-1.1% | 5/15/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $8.00 -> $7.00 | Medium | View details for Cantor Fitzgerald rating of Exagen (NASDAQ:XGN) on 5/15/2025 |
RBRK Rubrik | $93.27
-4.7% | 5/15/2025 | Target Raised by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $85.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 5/15/2025 |
VNDA Vanda Pharmaceuticals | $4.59
-0.4% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst O. Brayer | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 5/13/2025 |
FULC Fulcrum Therapeutics | $7.12
-1.8% | 5/15/2025 | Upgraded by | Cantor Fitzgerald | Analyst Kristen Kluska | Neutral -> Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/15/2025 |
STOK Stoke Therapeutics | $11.13
-0.1% | 5/14/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 5/14/2025 |
SLDB Solid Biosciences | $4.62
+1.8% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Solid Biosciences (NASDAQ:SLDB) on 5/13/2025 |
PRTA Prothena | $5.25
-3.0% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst E. Schmidt | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 5/13/2025 |
MNMD Mind Medicine (MindMed) | $7.76
-0.4% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 5/13/2025 |
HRMY Harmony Biosciences | $35.42
-0.5% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 5/13/2025 |
GHRS GH Research | $13.70
+9.6% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Strong-Buy | | High | View details for Cantor Fitzgerald rating of GH Research (NASDAQ:GHRS) on 5/13/2025 |
DRUG Bright Minds Biosciences | $27.88
+1.0% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Bright Minds Biosciences (NASDAQ:DRUG) on 5/13/2025 |
CYTK Cytokinetics | $33.13
+2.6% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Gould | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Cytokinetics (NASDAQ:CYTK) on 5/13/2025 |
CYBN Cybin | $8.45
-5.1% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Cybin (NYSE:CYBN) on 5/13/2025 |
CMPS COMPASS Pathways | $4.67
-2.7% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 5/13/2025 |
BHVN Biohaven | $17.08
+0.3% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 5/13/2025 |
AXSM Axsome Therapeutics | $109.87
-1.8% | 5/14/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/14/2025 |
ATAI Atai Life Sciences | $2.28
-5.4% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | N/A | View details for Cantor Fitzgerald rating of Atai Life Sciences (NASDAQ:ATAI) on 5/13/2025 |
ALKS Alkermes | $31.14
-1.8% | 5/13/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Stavropoulos | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 5/13/2025 |
PHVS Pharvaris | $18.03
+7.4% | 5/14/2025 | Target Lowered by | Cantor Fitzgerald | Analyst S. Seedhouse | Overweight -> Overweight | $28.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of Pharvaris (NASDAQ:PHVS) on 5/14/2025 |
CAPR Capricor Therapeutics | $13.38
-6.0% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $30.00 -> $30.00 | Medium | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/14/2025 |
LEGN Legend Biotech | $34.78
-0.6% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Rick Bienkowski | Overweight -> Overweight | $55.00 -> $55.00 | High | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 5/14/2025 |
LUNR Intuitive Machines | $11.79
+0.7% | 5/14/2025 | Target Raised by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $13.00 -> $16.00 | High | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 5/14/2025 |
NPCE NeuroPace | $12.93
-1.7% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $17.00 -> $17.00 | High | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 5/14/2025 |
VNDA Vanda Pharmaceuticals | $4.59
-0.4% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight | $13.00 | Low | View details for Cantor Fitzgerald rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 5/14/2025 |
ABNB Airbnb | $139.01
-1.2% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Underweight -> Underweight | $100.00 -> $100.00 | Medium | View details for Cantor Fitzgerald rating of Airbnb (NASDAQ:ABNB) on 5/14/2025 |
ATXS Astria Therapeutics | $5.79
-3.3% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst S. Seedhouse | Overweight -> Overweight | $47.00 -> $47.00 | Medium | View details for Cantor Fitzgerald rating of Astria Therapeutics (NASDAQ:ATXS) on 5/14/2025 |
ZVRA Zevra Therapeutics | $9.19
-0.8% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 5/14/2025 |
SSTI SoundThinking | $16.30
+0.3% | 5/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $20.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 5/14/2025 |
CYBR CyberArk Software | $397.94
-1.4% | 5/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $400.00 -> $400.00 | High | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 5/13/2025 |
ASND Ascendis Pharma A/S | $173.15
+0.1% | 5/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/12/2025 |
VERA Vera Therapeutics | $22.19
-2.2% | 5/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Pete Stavropoulos | Overweight -> Overweight | $107.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Vera Therapeutics (NASDAQ:VERA) on 5/7/2025 |
DDOG Datadog | $121.17
-0.8% | 5/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $134.00 -> $134.00 | Low | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 5/7/2025 |
RIVN Rivian Automotive | $14.40
+2.9% | 5/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Neutral | $15.00 -> $15.00 | High | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 5/7/2025 |
LCID Lucid Group | $2.23
+3.7% | 5/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 5/7/2025 |
SRPT Sarepta Therapeutics | $39.71
-7.7% | 5/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $163.00 -> $81.00 | High | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/7/2025 |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
RIGL Rigel Pharmaceuticals | $21.85
+1.7% | 5/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Neutral -> Neutral | $20.00 -> $23.00 | High | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 5/7/2025 |
PTCT PTC Therapeutics | $51.69
-0.8% | 5/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $113.00 -> $112.00 | High | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 5/7/2025 |
XMTR Xometry | $36.20
-1.5% | 5/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Underweight -> Underweight | $20.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Xometry (NASDAQ:XMTR) on 5/7/2025 |
AMD Advanced Micro Devices | $121.73
+4.8% | 5/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $120.00 -> $120.00 | High | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 5/7/2025 |
VRNS Varonis Systems | $50.65
+0.0% | 5/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $60.00 -> $60.00 | Low | View details for Cantor Fitzgerald rating of Varonis Systems (NASDAQ:VRNS) on 5/7/2025 |
PACK Ranpak | $3.68
+1.1% | 5/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $11.50 -> $6.00 | High | View details for Cantor Fitzgerald rating of Ranpak (NYSE:PACK) on 5/7/2025 |
DASH DoorDash | $217.49
-0.4% | 5/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $210.00 -> $210.00 | High | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 5/7/2025 |
MRVL Marvell Technology | $69.14
+1.2% | 5/7/2025 | Downgraded by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Neutral | $125.00 -> $60.00 | High | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 5/7/2025 |
ORIC ORIC Pharmaceuticals | $9.86
+5.8% | 5/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Prakhar Agrawal | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 5/6/2025 |
SIBN SI-BONE | $18.86
-0.2% | 5/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 5/6/2025 |
PLTR Palantir Technologies | $132.06
+3.4% | 5/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $98.00 -> $110.00 | High | View details for Cantor Fitzgerald rating of Palantir Technologies (NASDAQ:PLTR) on 5/6/2025 |
VRTX Vertex Pharmaceuticals | $446.15
-1.0% | 5/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Gould | Overweight -> Overweight | $535.00 -> $535.00 | High | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/6/2025 |
GFS GlobalFoundries | $38.39
+1.7% | 5/5/2025 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | | High | View details for Cantor Fitzgerald rating of GlobalFoundries (NASDAQ:GFS) on 5/5/2025 |
SNAP Snap | $8.52
+3.0% | 4/30/2025 | Target Set by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $7.00 | Low | View details for Cantor Fitzgerald rating of Snap (NYSE:SNAP) on 4/30/2025 |
FROG JFrog | $42.44
-0.7% | 5/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $46.00 -> $46.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 5/5/2025 |
MSTR Strategy | $392.12
+4.7% | 5/5/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $619.00 -> $614.00 | Low | View details for Cantor Fitzgerald rating of Strategy (NASDAQ:MSTR) on 5/5/2025 |
ONTO Onto Innovation | $99.45
+3.5% | 5/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Neutral | $250.00 -> $135.00 | Low | View details for Cantor Fitzgerald rating of Onto Innovation (NYSE:ONTO) on 5/5/2025 |
JOBY Joby Aviation | $9.24
+13.8% | 5/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $9.00 | Low | View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 5/5/2025 |
AMZN Amazon.com | $216.98
+1.6% | 5/2/2025 | Target Raised by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $230.00 -> $240.00 | Medium | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 5/2/2025 |
ABNB Airbnb | $139.01
-1.2% | 5/2/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Underweight -> Underweight | $101.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Airbnb (NASDAQ:ABNB) on 5/2/2025 |
MSFT Microsoft | $472.75
+0.5% | 5/1/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $502.00 -> $512.00 | Medium | View details for Cantor Fitzgerald rating of Microsoft (NASDAQ:MSFT) on 5/1/2025 |
HOOD Robinhood Markets | $73.40
-2.0% | 5/1/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $62.00 -> $60.00 | High | View details for Cantor Fitzgerald rating of Robinhood Markets (NASDAQ:HOOD) on 5/1/2025 |
META Meta Platforms | $694.06
-0.5% | 5/1/2025 | Target Raised by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $624.00 -> $676.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 5/1/2025 |
EBAY eBay | $79.36
+1.0% | 5/1/2025 | Target Raised by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $65.00 -> $69.00 | Low | View details for Cantor Fitzgerald rating of eBay (NASDAQ:EBAY) on 5/1/2025 |
ETSY Etsy | $63.88
+0.1% | 5/1/2025 | Target Raised by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $42.00 -> $47.00 | Low | View details for Cantor Fitzgerald rating of Etsy (NASDAQ:ETSY) on 5/1/2025 |
KLAC KLA | $829.29
+2.6% | 5/1/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $800.00 -> $800.00 | High | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 5/1/2025 |
QCOM QUALCOMM | $155.41
+4.1% | 5/1/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $150.00 -> $150.00 | Medium | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 5/1/2025 |
UDMY Udemy | $7.51
-1.2% | 5/1/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Yi Fu Lee | Overweight -> Overweight | $11.00 -> $9.00 | Medium | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 5/1/2025 |
HUM Humana | $233.04
+1.0% | 5/1/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Neutral -> Neutral | $290.00 -> $290.00 | Medium | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 5/1/2025 |
ETNB 89bio | $10.57
+3.1% | 4/30/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. Seedhouse | Strong-Buy | | High | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 4/30/2025 |
VKTX Viking Therapeutics | $27.57
-0.9% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. Seedhouse | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Viking Therapeutics (NASDAQ:VKTX) on 4/29/2025 |
KRRO Korro Bio | $14.85
+1.8% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. Seedhouse | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Korro Bio (NASDAQ:KRRO) on 4/29/2025 |
EDIT Editas Medicine | $1.93
+1.0% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst E. Schmidt | Hold -> Strong-Buy | | High | View details for Cantor Fitzgerald rating of Editas Medicine (NASDAQ:EDIT) on 4/29/2025 |
ATXS Astria Therapeutics | $5.79
-3.3% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. Seedhouse | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Astria Therapeutics (NASDAQ:ATXS) on 4/29/2025 |
APLS Apellis Pharmaceuticals | $19.39
+0.6% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Eliana Merle | Overweight | $44.00 | Low | View details for Cantor Fitzgerald rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/29/2025 |
PHVS Pharvaris | $18.03
+7.4% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $28.00 | Medium | View details for Cantor Fitzgerald rating of Pharvaris (NASDAQ:PHVS) on 4/29/2025 |
WVE Wave Life Sciences | $7.05
-2.4% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of Wave Life Sciences (NASDAQ:WVE) on 4/29/2025 |
PRQR ProQR Therapeutics | $1.83
-4.2% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst S. Seedhouse | Overweight | $8.00 | High | View details for Cantor Fitzgerald rating of ProQR Therapeutics (NASDAQ:PRQR) on 4/29/2025 |
BCRX BioCryst Pharmaceuticals | $11.11
+0.6% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $20.00 | Medium | View details for Cantor Fitzgerald rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 4/29/2025 |
IFRX InflaRx | $0.85
+2.4% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of InflaRx (NASDAQ:IFRX) on 4/29/2025 |
ATXS Astria Therapeutics | $5.79
-3.3% | 4/28/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $47.00 | Low | View details for Cantor Fitzgerald rating of Astria Therapeutics (NASDAQ:ATXS) on 4/28/2025 |
KRRO Korro Bio | $14.85
+1.8% | 4/28/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $74.00 | High | View details for Cantor Fitzgerald rating of Korro Bio (NASDAQ:KRRO) on 4/28/2025 |
VKTX Viking Therapeutics | $27.57
-0.9% | 4/28/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $104.00 | High | View details for Cantor Fitzgerald rating of Viking Therapeutics (NASDAQ:VKTX) on 4/28/2025 |
CGON CG Oncology | $27.00
+0.3% | 4/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $75.00 -> $75.00 | High | View details for Cantor Fitzgerald rating of CG Oncology (NASDAQ:CGON) on 4/28/2025 |
TSHA Taysha Gene Therapies | $2.80
-1.4% | 4/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $7.00 -> $7.00 | Medium | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/28/2025 |
AMD Advanced Micro Devices | $121.73
+4.8% | 4/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst C J Muse | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 4/28/2025 |
UAL United Airlines | $83.47
-0.9% | 4/22/2025 | Target Set by | Cantor Fitzgerald | Analyst Tom Fitzgerald | | $88.00 | Low | View details for Cantor Fitzgerald rating of United Airlines (NASDAQ:UAL) on 4/22/2025 |
GOOG Alphabet | $177.63
+1.5% | 4/25/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $171.00 | High | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOG) on 4/25/2025 |
LRCX Lam Research | $88.30
+2.3% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/24/2025 |
FTNT Fortinet | $102.08
-2.7% | 4/24/2025 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $115.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/24/2025 |
Why Elon put $51 million into this (Ad) Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists [See The Details Here] |
CYBR CyberArk Software | $397.94
-1.4% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/24/2025 |
NOW ServiceNow | $1,027.05
-0.3% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $1,048.00 -> $1,048.00 | Low | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 4/24/2025 |
PI Impinj | $117.01
+3.1% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $133.00 -> $133.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 4/24/2025 |
TXN Texas Instruments | $199.21
+3.5% | 4/24/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $200.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2025 |
TSLA Tesla | $308.58
+4.6% | 4/23/2025 | Target Lowered by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $425.00 -> $355.00 | High | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 4/23/2025 |
TVTX Travere Therapeutics | $14.91
-2.7% | 4/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 4/23/2025 |
SMMT Summit Therapeutics | $21.56
+4.7% | 4/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Summit Therapeutics (NASDAQ:SMMT) on 4/23/2025 |
ELV Elevance Health | $389.66
-0.9% | 4/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $485.00 -> $485.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/23/2025 |
CRM Salesforce | $272.36
-0.8% | 4/23/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $210.00 | Medium | View details for Cantor Fitzgerald rating of Salesforce (NYSE:CRM) on 4/23/2025 |
SMRT SmartRent | $0.92
0.0% | 4/22/2025 | Upgraded by | Cantor Fitzgerald | Analyst Y. Lee | Hold | | High | View details for Cantor Fitzgerald rating of SmartRent (NYSE:SMRT) on 4/22/2025 |
ABBV AbbVie | $189.13
-0.4% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $210.00 | Medium | View details for Cantor Fitzgerald rating of AbbVie (NYSE:ABBV) on 4/22/2025 |
BMY Bristol-Myers Squibb | $49.01
+1.2% | 4/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Carter Gould | Neutral -> Neutral | $55.00 -> $55.00 | Medium | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 4/22/2025 |
MRK Merck & Co., Inc. | $79.30
+0.4% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Neutral | $85.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/22/2025 |
PCVX Vaxcyte | $37.20
+0.6% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | | High | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 4/22/2025 |
PFE Pfizer | $23.97
+2.6% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight -> Neutral | $24.00 | Medium | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/22/2025 |
VRTX Vertex Pharmaceuticals | $446.15
-1.0% | 4/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $535.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/22/2025 |
LLY Eli Lilly and Company | $773.59
+0.5% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $975.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/22/2025 |
AMGN Amgen | $289.98
-0.1% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Gould | Overweight -> Neutral | $305.00 | Medium | View details for Cantor Fitzgerald rating of Amgen (NASDAQ:AMGN) on 4/22/2025 |
GILD Gilead Sciences | $113.00
+0.5% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $125.00 | Medium | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 4/22/2025 |
REGN Regeneron Pharmaceuticals | $517.60
+4.9% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $695.00 | High | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/22/2025 |
INTC Intel | $20.48
+2.1% | 4/21/2025 | Target Lowered by | Cantor Fitzgerald | - | Neutral | $29.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 4/21/2025 |
VRNA Verona Pharma | $84.64
+0.4% | 4/21/2025 | Initiated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight | $80.00 | Low | View details for Cantor Fitzgerald rating of Verona Pharma (NASDAQ:VRNA) on 4/21/2025 |
ABNB Airbnb | $139.01
-1.2% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Underweight -> Underweight | $130.00 -> $101.00 | Low | View details for Cantor Fitzgerald rating of Airbnb (NASDAQ:ABNB) on 4/16/2025 |
BKNG Booking | $5,539.41
-1.3% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $5,540.00 -> $4,330.00 | Low | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 4/16/2025 |
DASH DoorDash | $217.49
-0.4% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $230.00 -> $210.00 | Low | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 4/16/2025 |
GOOGL Alphabet | $176.09
+1.4% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 -> $159.00 | Low | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 4/16/2025 |
MELI MercadoLibre | $2,448.60
-1.4% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $3,000.00 -> $2,400.00 | Low | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 4/16/2025 |
META Meta Platforms | $694.06
-0.5% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $790.00 -> $624.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 4/16/2025 |
SHOP Shopify | $107.80
-3.2% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $120.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 4/16/2025 |
SPOT Spotify Technology | $699.13
-1.8% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $600.00 -> $520.00 | Low | View details for Cantor Fitzgerald rating of Spotify Technology (NYSE:SPOT) on 4/16/2025 |
UBER Uber Technologies | $87.19
+1.9% | 4/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $80.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 4/16/2025 |
NVDA NVIDIA | $142.63
+0.6% | 4/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 4/16/2025 |
NOW ServiceNow | $1,027.05
-0.3% | 4/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $1,048.00 -> $1,048.00 | High | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 4/16/2025 |
AMZN Amazon.com | $216.98
+1.6% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $270.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 4/16/2025 |
APLD Applied Digital | $13.02
-6.1% | 4/15/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $14.00 -> $7.00 | High | View details for Cantor Fitzgerald rating of Applied Digital (NASDAQ:APLD) on 4/15/2025 |
VERV Verve Therapeutics | $6.10
-1.6% | 4/15/2025 | Upgraded by | Cantor Fitzgerald | Analyst Rick Bienkowski | Neutral -> Overweight | | High | View details for Cantor Fitzgerald rating of Verve Therapeutics (NASDAQ:VERV) on 4/15/2025 |
DNLI Denali Therapeutics | $14.65
-0.3% | 4/10/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Neutral -> Overweight | | High | View details for Cantor Fitzgerald rating of Denali Therapeutics (NASDAQ:DNLI) on 4/10/2025 |
COIN Coinbase Global | $256.63
+2.1% | 4/8/2025 | Initiated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight | $245.00 | High | View details for Cantor Fitzgerald rating of Coinbase Global (NASDAQ:COIN) on 4/8/2025 |
FIVN Five9 | $29.56
+1.4% | 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 4/2/2025 |
SNOW Snowflake | $210.75
0.0% | 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $183.00 | High | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 4/2/2025 |
TVTX Travere Therapeutics | $14.91
-2.7% | 4/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 4/3/2025 |
LCID Lucid Group | $2.23
+3.7% | 4/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | Medium | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 4/3/2025 |
TSLA Tesla | $308.58
+4.6% | 4/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $425.00 -> $425.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 4/3/2025 |
ZS Zscaler | $299.90
-1.0% | 4/3/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Overweight | $220.00 -> $250.00 | High | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/3/2025 |
MESO Mesoblast | $11.85
+0.5% | 3/31/2025 | Upgraded by | Cantor Fitzgerald | Analyst O. Brayer | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 3/31/2025 |
META Meta Platforms | $694.06
-0.5% | 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $790.00 -> $790.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 4/2/2025 |
ITCI Intra-Cellular Therapies | $131.87
| 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Neutral -> Neutral | $132.00 -> $132.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/2/2025 |
TEAM Atlassian | $214.99
+0.2% | 4/2/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Overweight | $304.00 -> $272.00 | High | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 4/2/2025 |
AARD Aardvark Therapeutics | $11.68
-1.1% | 4/1/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $50.00 -> $50.00 | High | View details for Cantor Fitzgerald rating of Aardvark Therapeutics (NASDAQ:AARD) on 4/1/2025 |
IMTX Immatics | $6.00
+0.5% | 4/1/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Immatics (NASDAQ:IMTX) on 4/1/2025 |
Elon’s NEXT Big IPO? (Ad) Cancel your internet TODAY!?
Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up.
It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry.
But you may only have this chance if you act before December 31st, 2025. One that experts predict could be worth over $3.2 TRILLION globally by 2030. |
NNOX Nano-X Imaging | $5.52
-0.2% | 4/1/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $12.00 -> $9.00 | High | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 4/1/2025 |
TENB Tenable | $32.55
-1.0% | 3/31/2025 | Initiated by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight | $50.00 | High | View details for Cantor Fitzgerald rating of Tenable (NASDAQ:TENB) on 3/31/2025 |
OKTA Okta | $101.20
-3.7% | 3/31/2025 | Initiated by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight | $130.00 | Medium | View details for Cantor Fitzgerald rating of Okta (NASDAQ:OKTA) on 3/31/2025 |
DDD 3D Systems | $1.85
+6.6% | 3/28/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $5.75 -> $5.00 | Medium | View details for Cantor Fitzgerald rating of 3D Systems (NYSE:DDD) on 3/28/2025 |
LCID Lucid Group | $2.23
+3.7% | 3/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 3/28/2025 |
CMPS COMPASS Pathways | $4.67
-2.7% | 3/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 3/28/2025 |
ZLAB Zai Lab | $37.87
-0.6% | 3/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 3/27/2025 |
SLNO Soleno Therapeutics | $77.73
+2.9% | 3/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $67.00 -> $123.00 | High | View details for Cantor Fitzgerald rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/27/2025 |
ACRV Acrivon Therapeutics | $1.28
-5.2% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/26/2025 |
XFOR X4 Pharmaceuticals | $4.14
-3.7% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/26/2025 |
LUCD Lucid Diagnostics | $1.30
+0.8% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $2.00 -> $2.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/26/2025 |
SMTI Sanara MedTech | $29.07
-1.4% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $46.00 -> $46.00 | Medium | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/26/2025 |
ARTV Artiva Biotherapeutics | $2.11
+0.5% | 3/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $23.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/25/2025 |
LUNR Intuitive Machines | $11.79
+0.7% | 3/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $15.00 -> $13.00 | Medium | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/25/2025 |
OUST Ouster | $15.19
+4.1% | 3/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $10.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/21/2025 |
MU Micron Technology | $110.95
+2.2% | 3/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $130.00 -> $130.00 | High | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/21/2025 |
PL Planet Labs PBC | $5.85
+0.2% | 3/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $6.30 -> $6.30 | High | View details for Cantor Fitzgerald rating of Planet Labs PBC (NYSE:PL) on 3/21/2025 |
SMMT Summit Therapeutics | $21.56
+4.7% | 3/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Summit Therapeutics (NASDAQ:SMMT) on 3/21/2025 |
GLYC GlycoMimetics | $0.18
-8.9% | 3/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of GlycoMimetics (NASDAQ:GLYC) on 3/21/2025 |
ALMS Alumis | $3.43
-4.5% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 3/20/2025 |
DOMO Domo | $14.25
-2.6% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $11.00 -> $11.00 | Medium | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 3/20/2025 |
CI The Cigna Group | $311.33
-0.3% | 3/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $350.00 -> $365.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 3/20/2025 |
CAPR Capricor Therapeutics | $13.38
-6.0% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/20/2025 |
TWI Titan International | $9.33
+15.0% | 3/20/2025 | Initiated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight | $11.00 | High | View details for Cantor Fitzgerald rating of Titan International (NYSE:TWI) on 3/20/2025 |
GOOG Alphabet | $177.63
+1.5% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOG) on 3/19/2025 |
NVDA NVIDIA | $142.63
+0.6% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/19/2025 |
GOOGL Alphabet | $176.09
+1.4% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 3/19/2025 |
TSLA Tesla | $308.58
+4.6% | 3/19/2025 | Upgraded by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Overweight | $425.00 -> $425.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 3/19/2025 |
IRON Disc Medicine | $51.42
+2.8% | 3/18/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $99.00 -> $132.00 | Medium | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 3/18/2025 |
BLTE Belite Bio | $61.40
+2.9% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of Belite Bio (NASDAQ:BLTE) on 3/18/2025 |
MREO Mereo BioPharma Group | $2.65
-3.3% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $7.00 -> $7.00 | High | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/18/2025 |
SRPT Sarepta Therapeutics | $39.71
-7.7% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $163.00 -> $163.00 | High | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/18/2025 |
ACRS Aclaris Therapeutics | $1.49
-2.6% | 3/18/2025 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 3/18/2025 |
RBRK Rubrik | $93.27
-4.7% | 3/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $85.00 -> $85.00 | High | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 3/14/2025 |
EVEX EVE | $5.64
+3.5% | 3/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | High | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 3/14/2025 |
NVMI Nova | $220.89
+1.8% | 3/14/2025 | Target Lowered by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $315.00 -> $300.00 | Low | View details for Cantor Fitzgerald rating of Nova (NASDAQ:NVMI) on 3/14/2025 |
TARA Protara Therapeutics | $3.27
-2.1% | 3/14/2025 | Initiated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight | | Low | View details for Cantor Fitzgerald rating of Protara Therapeutics (NASDAQ:TARA) on 3/14/2025 |
BCAX Bicara Therapeutics | $11.48
-0.2% | 3/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | $13.01 -> $13.01 | Medium | View details for Cantor Fitzgerald rating of Bicara Therapeutics (NASDAQ:BCAX) on 3/13/2025 |
S SentinelOne | $18.12
-1.3% | 3/13/2025 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $30.00 -> $24.00 | High | View details for Cantor Fitzgerald rating of SentinelOne (NYSE:S) on 3/13/2025 |
ZVRA Zevra Therapeutics | $9.19
-0.8% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/12/2025 |
TER Teradyne | $86.80
+1.8% | 3/12/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $150.00 -> $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/12/2025 |
BEAM Beam Therapeutics | $18.17
-2.2% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst R. Bienkowski | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 3/12/2025 |
VYGR Voyager Therapeutics | $3.35
-5.4% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/12/2025 |
ORCL Oracle | $177.19
+1.8% | 3/11/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $214.00 -> $175.00 | High | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 3/11/2025 |
NOW ServiceNow | $1,027.05
-0.3% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $1,048.00 -> $1,048.00 | Low | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 3/11/2025 |
LFMD LifeMD | $12.45
-2.1% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $15.00 -> $15.00 | High | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 3/11/2025 |
TBRG TruBridge | $24.17
+1.5% | 3/11/2025 | Target Raised by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $20.00 -> $29.00 | High | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/11/2025 |
RDW Redwire | $20.04
+8.6% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $28.00 -> $28.00 | Medium | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 3/11/2025 |
HIVE HIVE Digital Technologies | $2.01
| 3/11/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $10.00 -> $8.00 | Medium | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 3/11/2025 |
AARD Aardvark Therapeutics | $11.68
-1.1% | 3/10/2025 | Initiated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight | $50.00 | High | View details for Cantor Fitzgerald rating of Aardvark Therapeutics (NASDAQ:AARD) on 3/10/2025 |
WDC Western Digital | $57.02
+2.8% | 3/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 3/7/2025 |
ADCT ADC Therapeutics | $3.57
-2.7% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of ADC Therapeutics (NYSE:ADCT) on 3/7/2025 |
ARCT Arcturus Therapeutics | $12.54
-2.0% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Pete Stavropoulos | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/7/2025 |
AVGO Broadcom | $244.28
-1.1% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $300.00 -> $300.00 | High | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 3/7/2025 |
ELUT Elutia | $1.89
-0.5% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $8.00 -> $8.00 | High | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 3/7/2025 |
DOMO Domo | $14.25
-2.6% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $11.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 3/7/2025 |
BBAI BigBear.ai | $3.89
+1.0% | 3/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $8.00 -> $6.00 | Medium | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 3/7/2025 |
HUT Hut 8 | $18.55
-0.1% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 3/7/2025 |
HOOD Robinhood Markets | $73.40
-2.0% | 3/6/2025 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $69.00 | High | View details for Cantor Fitzgerald rating of Robinhood Markets (NASDAQ:HOOD) on 3/6/2025 |
NPCE NeuroPace | $12.93
-1.7% | 3/5/2025 | Target Raised by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $19.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/5/2025 |
